Growth trends across the India IT sector continue to diverge. While Tier-I companies are likely to post flat to marginal constant currency revenue movement, mid-tier firms are expected to outperform.
The initial public offer of Anthem Biosciences Ltd got subscribed 73 per cent on the first day of share sale on Monday. The initial share sale received bids for 3,21,13,406 shares against 4,40,70,682 shares on offer, according to NSE data. Non-institutional Investors category garnered 1.55 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 58 per cent. The portion for Qualified Institutional Buyers (QIBs) received 37 per cent subscription. Anthem Biosciences has raised Rs 1,016 crore from anchor investors. The Rs 3,395-crore IPO of the Bengaluru-based firm will close on July 16. The price band has been fixed at Rs 540-570 per share. Since the IPO is entirely an offer-for-sale (OFS), the company will not receive any funds from the issue, and the proceeds will go to the selling shareholders. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operat
B&K Securities initiated coverage on Landmark Cars with a 'Buy' rating and a target price of ₹820 per share
At 10:25 AM, Castrol India shares were trading at ₹228.20, up by 3.78 per cent on the National Stock Exchange.
Asston Pharmaceuticals IPO allotment status: Investors can check their status on the official websites of BSE and Maashitla Securities
Shares of Indian stock exchanges NSE and BSE slump this week amid regulatory scrutiny over high-frequency trading and concerns over declining trading turnover
Anthem Biosciences IPO: The company has raised ₹1,016 crore from anchor investors ahead of its public issue
Stocks to buy: Analyst at Angel One recommends JSW Infra, Rallis India and one other stock; Check target price, stop loss here
Investors are hopeful that a more coordinated policy response to tackle the drivers of deflation is on its way, though Beijing hasn't yet released any plan
Glenmark's $700 million deal with AbbVie for ISB-2001 could unlock significant upside, though analysts note the potential is already priced in, with stock surging post-announcement
Madhya Bharat Agro share price was trading 1 per cent higher at ₹422.45 compared to Thursday's close of ₹418.15
Broader markets were also trading in red. The Nifty Midcap 100 was trading at 58,749, down by 0.69 per cent.
Analysts at JP Morgan believe Vedanta is cheap within the Asian and emerging market (EM) metals and mining space
Q1 FY26 company results, July 11: 14 companies will be releasing their performance reports for the April-June quarter today
F&O strategy: Primary trend of the Bank Nifty remains positive as it is placed above its 50 and 100 day EMA
This is the sharpest surge recorded across states during this period, and reflects a compound annual growth rate (CAGR) of 48.8 per cent
Monica Alcobev plans to use the net fresh issue proceeds for working capital requirements, repayment of debt and general corporate purposes
Asston Pharmaceutical IPO was oversubscribed by 6.26 times, receiving bids for 10 million shares against 1.6 million shares on offer.
The unlisted shares of Glen Industries were trading at ₹132, commanding a GMP of ₹35 or 36.08 per cent compared to the upper end of the price band of ₹92 to ₹97
After the listing, shares of Happy Square Outsourcing were trading at ₹80.85, up 5 per cent from the opening price